The opposite occurs when the mutation involves a P2X7 receptor gain-of-function that increases receptor channel permeability for Ca2+ such as the Ala76Val polymorphism, which is more common in MS patients (Oyanguren-Desez et al., 2011) (Figure 2). Here, P2RX7 is linked to myeloid sarcoma.